Von Eschenbach steps up as Crawford calls it a day on uneasy tenure of FDA
This article was originally published in Clinica
Executive Summary
Embattled FDA commissioner Lester Crawford resigned unexpectedly late on Friday September 23, and the director of the National Cancer Institute, Andrew von Eschenbach was immediately named acting commissioner.